Cargando…
The Matrix Metalloproteinase-3 (MMP-3) 5A/6A Promoter Polymorphism Is Not Associated with Ischaemic Heart Disease: Analysis Employing a Family Based Approach
Matrix metalloproteinase-3 (MMP-3) has been proposed as an important mediator of the atherosclerotic process. The possible role of the functional -1612 5A/6A polymorphism of the MMP-3 gene in the susceptibility to ischaemic heart disease (IHD) was investigated in a well-defined Irish population usin...
Autores principales: | McGlinchey, Paul G., Spence, Mark S., Patterson, Chris C., Allen, Adrian R., Murphy, Gillian, Fogarty, Damian, Evans, Alun, McKeown, Pascal P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839324/ https://www.ncbi.nlm.nih.gov/pubmed/15665388 http://dx.doi.org/10.1155/2004/715745 |
Ejemplares similares
-
Lack of MEF2A Δ7aa mutation in Irish families with early onset ischaemic heart disease, a family based study
por: Horan, Paul G, et al.
Publicado: (2006) -
Coexistence of supravalvular aortic stenosis and osteogenesis imperfecta.
por: McGlinchey, P. G., et al.
Publicado: (2001) -
New insights into the role of matrix metalloproteinase 3 (MMP3) in bone
por: Jehan, Frédéric, et al.
Publicado: (2022) -
Matrix metalloproteinase-3 (MMP-3)–mediated gene therapy for glaucoma
por: O’Callaghan, Jeffrey, et al.
Publicado: (2023) -
Matrix Metalloproteinases MMP2 and MMP9 Are Produced in Early Stages of Kidney Morphogenesis but Only MMP9 Is Required for Renal Organogenesis In Vitro
por: Lelongt, Brigitte, et al.
Publicado: (1997)